Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Replenix is a premier medical-grade skincare company that specializes in high-performance, antioxidant-based dermatological products. Founded in 1981 and operating as a flagship brand of Topix Pharmaceuticals, the company is renowned for its proprietary Green Tea Polyphenol Technology, which delivers highly purified antioxidants to the skin. Its product portfolio includes clinically-tested treatments for acne, aging, hyperpigmentation, and sensitive skin, featuring medical-grade ingredients such as all-trans-retinol and fractionated hyaluronic acid. Originally available exclusively through physician offices, Replenix expanded to a direct-to-consumer model in 2021 to broaden access to its science-backed skincare solutions. The company maintains vertical integration with in-house R&D and manufacturing facilities in New York.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Replenix.